Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin

Abevmy is abiosimilar to Roche's Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen, it said.

from Industry-Economic Times
Read The Rest:economictimes...

Post Top Ad